[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 454
Citations 0
News From the Food and Drug Administration
August 2, 2016

New Weapon Against Cholera

JAMA. 2016;316(5):485. doi:10.1001/jama.2016.9769

Travelers to cholera-affected parts of the world have a new defense against the bacterial infection. Vaxchora recently became the only FDA-approved vaccine for preventing cholera caused by serogroup O1 Vibrio cholerae (http://1.usa.gov/1XeF73f).

Although cholera is rare in the United States, a recent study reported that cholera is endemic in an estimated 69 countries, more than half of which are in sub-Saharan Africa (Ali M et al. PLoS Negl Trop Dis. 9[6]:e0003832). The study also noted that the illness causes about 2.9 million new cases and 95 000 deaths annually.

First Page Preview View Large
First page PDF preview
First page PDF preview